Steward Partners Investment Advisory’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.13K | Sell |
9
-12
| -57% | -$1.51K | ﹤0.01% | 3839 |
|
|
2025
Q1 | $2.32K | Hold |
21
| – | – | ﹤0.01% | 3610 |
|
|
2024
Q4 | $2.87K | Sell |
21
-100
| -83% | -$13.7K | ﹤0.01% | 3539 |
|
|
2024
Q3 | $13.9K | Buy |
121
+21
| +21% | +$2.42K | ﹤0.01% | 2815 |
|
|
2024
Q2 | $13.8K | Sell |
100
-459
| -82% | -$63.2K | ﹤0.01% | 2673 |
|
|
2024
Q1 | $77.1K | Buy |
559
+459
| +459% | +$63.3K | ﹤0.01% | 1887 |
|
|
2023
Q4 | $13.2K | Hold |
100
| – | – | ﹤0.01% | 2584 |
|
|
2023
Q3 | $11.3K | Hold |
100
| – | – | ﹤0.01% | 2550 |
|
|
2023
Q2 | $9.43K | Hold |
100
| – | – | ﹤0.01% | 2588 |
|
|
2023
Q1 | $10.1K | Hold |
100
| – | – | ﹤0.01% | 2534 |
|
|
2022
Q4 | $11.9K | Hold |
100
| – | – | ﹤0.01% | 2474 |
|
|
2022
Q3 | $11K | Buy |
+100
| New | +$11K | ﹤0.01% | 2492 |
|
|
2020
Q4 | – | Sell |
-36
| Closed | -$3K | – | 2959 |
|
|
2020
Q3 | $3K | Buy |
+36
| New | +$3K | ﹤0.01% | 2509 |
|
|
2020
Q1 | – | Sell |
-100
| Closed | -$10K | – | 2626 |
|
|
2019
Q4 | $10K | Hold |
100
| – | – | ﹤0.01% | 2018 |
|
|
2019
Q3 | $9K | Hold |
100
| – | – | ﹤0.01% | 2050 |
|
|
2019
Q2 | $8K | Buy |
+100
| New | +$8K | ﹤0.01% | 2079 |
|
|
2018
Q4 | – | Sell |
-1,029
| Closed | -$127K | – | 1640 |
|
|
2018
Q3 | $127K | Buy |
+1,029
| New | +$127K | 0.01% | 857 |
|